References
Arber DA, Orazi A, Hasserjian R et al (2016) The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood 127:2391–2405
Langabeer SE (2012) Referral centre variation in requesting JAK2 V617F mutation analysis for the investigation of a myeloproliferative neoplasm. J Clin Pathol 65:1149–1150
Gong JZ, Cook JR, Greiner RC et al (2013) Laboratory practice guidelines for detecting and reporting JAK2 and MPL mutations in myeloproliferative neoplasms: a report for the Association for Molecular Pathology. J Mol Diagn 15:733–744
Weir AB, Lewis JB Jr, Arteta-Bulos R (2011) Chronic idiopathic neutrophilia: experience and recommendations. South Med J 104:499–504
Ogunleye F, Ibrahim M, Allen E et al (2016) BCR-ABL testing by polymerase chain reaction in patients with neutrophilia: the William Beaumont Hospital experience and the case for rational laboratory tests request. J Oncol Pract 12:e1001–e1005
Tefferi A, Noel P, Hanson CA (2011) Uses and abuses of JAK2 and MPL mutation tests in myeloproliferative neoplasms. J Mol Diagn 13:461–466
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflicts of interest.
Rights and permissions
About this article
Cite this article
Langabeer, S.E., Haslam, K. Neutrophilia and the JAK2 V617F Mutation. Pathol. Oncol. Res. 25, 437–438 (2019). https://doi.org/10.1007/s12253-017-0315-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12253-017-0315-2